The other day, I came across a tablet which had an unusual shape of a regular hexagon (see image below). I wondered why would a pharma company make a tablet that is hexagonal in shape. The intuitive thing of course was to give the tablet only distinctiveness. But was it the only answer? Perhaps there were more parameters working there. So, I decided to get more gyan on this from my friendly AI.
Me:
Wanted to know how do pharma companies decide on shape, colour, and size of tablets? I understand a tablet can't be more than swallowing power of a normal person. As also, the size would be proportional to the active ingredients inside the tablets. But what about shape and colour? For example, this tablet is in the shape of a regular hexagon. Most tablets are round. Capsules are cylindrical with both ends rounded. Some tablets are flattened cylinders. Any particular theory behind this? Also, why do pharma companies imprint names in the tinniest of fonts? Although, tablets are prescribed to all ages, but the propensity would be for the elderly, would it not? The ones with failing eyesight?
AI:
Good question — there's actually a fair amount of deliberate science (and some non-science, like marketing and patents) behind tablet design.
Shape
- Round/circular is the default because it's the easiest and cheapest to tool and manufacture — round punches wear more evenly, compress more consistently, and are less prone to capping/chipping during high-speed production. That's why most generic tablets are round.
- Oval/capsule-shaped (caplets) are chosen mainly for swallowability. An oval or elongated shape reduces the "throat profile" — the cross-section your throat has to pass — compared to a round tablet of the same volume, so bigger doses (500mg, 1g) are often oval rather than round.
- Unusual shapes (hexagons, diamonds, triangles, your tablet pentagon/hexagon) usually exist for brand differentiation and anti-counterfeiting. A distinctive shape is trademarkable and lets patients/pharmacists visually confirm "yes, this is the real product" at a glance. It also helps patients on multiple medications tell their pills apart by feel/sight, which reduces dosing errors. Sometimes shape is also tied to how the tablet needs to break (e.g., shapes with a scored line for easy halving).
- Capsules are cylindrical with rounded ends purely for swallowing mechanics — the rounded ends reduce friction and the risk of catching in the esophagus, and the gelatin/HPMC shell shape is somewhat fixed by the manufacturing process (dip-molding on pins).
Colour
Colour is almost never functional (no drug requires a particular colour to work). Reasons companies pick specific colours:
1. Brand identity and trademark — colour becomes part of recognizing "my medication," similar to shape.
2. Patient adherence and error reduction — hospitals and patients often rely on colour to distinguish drugs, especially when someone takes many pills. Studies show patients are more likely to stop taking a "generic" if it suddenly changes colour after a formulation switch, because they no longer visually recognize it as the "same" medicine, even though it's identical.
3. Psychological association — there's real research showing colour affects perceived potency and even effect: red/orange tablets are perceived as more stimulating, blue/green as calming or sedative, warm colours as more effective painkillers in placebo studies. Companies do use this in choosing colours for the intended perception (e.g., sedatives are rarely bright red).
4. Masking or matching the active ingredient's natural colour, or hiding slight batch-to-batch colour variation in the raw material.
Size
As you noted — dictated by dose (amount of active + excipients/fillers needed to bind and compress it) and by practical swallowability limits. Companies do try to minimize excipient bulk to keep tablets as small as possible, especially for chronic-use drugs.
The tiny imprint
This one's a genuinely reasonable complaint you're making. A few things going on:
- Regulators (like the US FDA) actually require an imprint code (letters/numbers, sometimes a logo) on most solid oral dosage forms specifically so tablets/capsules can be identified after they're out of the bottle — say, if someone's hospitalized and no one knows what pill it is, or in poisoning/overdose cases. This is a safety requirement, not vanity.
- The imprint is deliberately small because it has to fit on a tablet that's already sized to the minimum swallowable volume — there's very little surface area on something 6-10mm across, and the imprint has to leave room for the score line, logo, and not weaken the tablet's structural integrity (deep engraving can create fracture points).
- You're right that this creates an accessibility gap for elderly patients or anyone with low vision. This is a recognized problem in pharmacy practice — it's part of why pill identification is more reliably done via pharmacist/pill-identifier databases and apps (using shape + colour + imprint together) rather than by patients reading the imprint themselves. The imprint is really designed for someone else — a pharmacist, ER doctor, or poison control — to read, not necessarily the patient day-to-day.
So the short version: shape and colour are largely branding, trademark, and human-factors tools (recognition, adherence, error-avoidance) rather than anything to do with the drug's chemistry; the imprint is a regulatory safety requirement optimized for professional identification rather than patient legibility.
Me:
What is more amenable to ingestion into human systems? Tablets, or liquid potions? All things being equal: for example, degree of difficulty in manufacturing, solubility, etc.
AI:
If you strip away manufacturing cost, shelf-stability, and practicality — and ask purely "which form gets the active drug into the bloodstream more efficiently" — liquids have the edge, for a fairly fundamental pharmacokinetic reason.
Why liquids absorb faster/more completely, in principle
A tablet, once swallowed, has to go through a sequence of steps before the drug can even reach the bloodstream:
1. Disintegration — the tablet breaks into granules
2. Deaggregation — granules break into fine particles
3. Dissolution — those particles dissolve into solution
4. Absorption — only the dissolved drug can cross the gut membrane
A liquid (true solution, not suspension) skips steps 1–3 entirely. The drug is already dissolved, so it's immediately available for absorption the moment it hits the stomach/intestine. This is why dissolution is often the rate-limiting step for tablets — pharmaceutical scientists spend enormous effort optimizing tablet disintegration/dissolution precisely because that's the bottleneck liquids don't have.
This is also why you'll notice:
- Pediatric and geriatric formulations skew liquid — faster onset, easier titration
- Emergency/acute-care drugs (e.g., some cardiac or antiemetic drugs) are often given as liquids, sublingual, or IV rather than solid tablets
- Bioequivalence studies use an oral solution as the theoretical "reference" against which a tablet's relative bioavailability is often benchmarked
Where tablets catch up or win, though
"All things being equal" doesn't fully hold in practice, because:
- Chemical stability: many drugs are far more stable as a dry solid than dissolved in water — hydrolysis, oxidation, and microbial growth are all faster in liquid form. This is why syrups need preservatives and shorter shelf lives, and why some drugs are literally impossible to formulate as stable liquids and only exist as tablets/capsules.
- First-pass metabolism: this is a systemic factor unrelated to formulation for most oral drugs — both tablets and liquids taken orally go through the liver first. (This only differs if you compare oral to sublingual/buccal/IV routes, which bypass first-pass regardless of solid or liquid form.)
- Dosing accuracy: a tablet delivers a fixed, precise dose every time. Liquids depend on the patient measuring correctly (a notoriously error-prone step — think of how inconsistently people use a kitchen spoon vs. a proper oral syringe).
- Gastric irritation and taste: some drugs are unpalatable or damaging to the stomach lining in concentrated liquid form and are deliberately given as enteric-coated or delayed-release tablets to control where and when they dissolve — something a liquid can't easily do. Modified-release tablets can actually outperform liquids for drugs where you want a slow, sustained absorption curve rather than a spike.
- Some drugs are insoluble or unstable in any aqueous vehicle at all, regardless of effort — solubility isn't just an engineering problem, it's dictated by the molecule's chemistry.
Net take
So the honest answer is: liquids win on pure absorption kinetics because they remove the dissolution bottleneck — but "amenable to ingestion" in the everyday clinical sense (accuracy, stability, control of release site/timing, patient convenience) often favors tablets, which is why they dominate the market despite the kinetic disadvantage.
No comments:
Post a Comment